WebJul 8, 2024 · The US Food and Drug Administration (“FDA”) reports the following Metformin medications are subject to this recall: Granules Pharmaceuticals Metformin … WebJul 8, 2024 · Granules India Ltd. is voluntarily recalling 12 lots of its type 2 diabetes drug metformin hydrochloride in the U.S. after detecting a potentially cancer-causing impurity. The recall was issued due to the presence of higher than acceptable daily intake levels of an impurity called N-Nitrosodimethylamine, or NDMA, Granules said in a company ...
Granules Pharma Recalls Diabetes Drug Metformin HCI Extended …
WebJul 13, 2024 · Granules Pharmaceuticals, Inc. said that there are no adverse reactions or illnesses linked to the recalled medication. The company also said that its Metformin immediate-release tablets in 500, 850, and 1,000 mg doses are unaffected by this voluntary recall. Granules Pharmaceuticals, Inc. conducted tests on its Metformin medications. WebJul 15, 2024 · By Nena Kotsalidis and Rosalind Lucier. The FDA has announced that 14 companies have voluntarily recalled their extended release metformin due to the possibility that it includes unsafe levels of NDMA, a toxic substance. Editor's note: This article was first published on July 15, 2024 and has since been updated to reflect the latest recalls. hint 2022 hamburg
A diabetes drug has been recalled because it contains high levels …
WebJul 9, 2024 · Granules Pharmaceuticals, Inc., recalled 12 lots of its Metformin Hydrochloride Extended-Release Tablets USP, 750 mg, 100 and 500 count. NDMA is a probable human carcinogen, meaning it could … WebAug 6, 2024 · Granules Pharmaceuticals recalled 12 lots of its metformin tablets. Lupin Pharmaceuticals recalled all lots of its metformin extended-release tablets. Marksans Pharma Limited recalled one lot of ... WebJul 9, 2024 · Lupin Pharmaceuticals. On Wednesday, Lupin Pharmaceuticals recalled all batches of its Metformin Hydrochloride Extended-Release tablets in 500 and 1,000 mg … homepod target